In the relentless battle against the SARS-CoV-2 virus, the development of effective and efficient diagnostic tools is paramount. Immunoassays have emerged as vital instruments in this endeavor, providing qualitative insights into the presence of crucial immunoglobulins, IgG and IgM, within human serum, whole blood, or plasma samples. These immunoassays operate with remarkable speed, delivering results in a mere 10-15 minutes.

Lateral Flow Immunoassay Chromatography:

These rapid tests operate on the principles of lateral flow immunoassay chromatography. They are ingeniously engineered in cassette form, facilitating ease of use and interpretation. At their core, they leverage capillary force to drive the separation of the components within a sample mixture and exploit the specific and rapid binding of antibodies to their target antigens.

IgM and IgG:

IgM and IgG, the immunoglobulins produced by the human immune system in response to SARS-CoV-2 infection, take center stage in these immunoassays. The presence and levels of anti-SARS-CoV-2 IgM and IgG antibodies in patient samples furnish crucial insights into the stage of infection and the body's immune response.

Versatile Kit Options:

Our offerings encompass a spectrum of kit types to cater to diverse research and diagnostic needs. Researchers and healthcare professionals can select kits tailored to detect either IgG, IgM, or both simultaneously. Moreover, comprehensive kits encompassing cassettes and sampling materials streamline the testing process, offering a holistic solution for efficient SARS-CoV-2 detection.